Mary Newman, SVP, Regulatory Affairs at Audentes Therapeutics, Inc. (BOLD), sold 16,790 shares at $40.77 ($685K) on 2018-06-25, disclosed to the SEC on 2018-06-27.
Open-market sale of $685k BOLD by SVP, Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.77 | 8,245 | $336K | 49.1% |
| 2 | $40.77 | 8,245 | $336K | 49.1% |
| 3 | $41.37 | 300 | $12K | 1.8% |
| Total | $40.78 avg | 16,790 | $685K | 100% |
| Filing → |
| BOLD | SELL | 2017-08-25 | $200K | — | Filing → |